- Coronary intravascular lithotripsy (IVL), a novel technique for treating calcified coronary lesions using sonic pressure waves to fracture hardened plaque, is emerging as a critical tool in modern interventional cardiology due to its precision, safety profile, and ability to improve stent expansion outcomes in complex cases
- The growing demand for IVL is primarily fueled by the increasing prevalence of coronary artery disease (CAD), a rise in percutaneous coronary intervention (PCI) procedures, and the need for safer alternatives to traditional plaque modification techniques such as rotational atherectomy
- North America dominated the coronary intravascular lithotripsy (IVL) market with the largest revenue share of 43% in 2024, supported by advanced healthcare infrastructure, early technology adoption, and favorable reimbursement policies, with the U.S. witnessing high procedural uptake driven by clinical endorsements, increased training programs, and regulatory support for innovative cardiovascular devices
- Asia-Pacific is expected to be the fastest growing region in the coronary intravascular lithotripsy (IVL) market during the forecast period due to a rising geriatric population, increasing awareness of advanced treatment options, and expanding access to interventional cardiology in emerging economies
- Coronary Intravascular Lithotripsy (IVL) Balloon Catheters segment dominated the coronary intravascular lithotripsy (IVL) market with a market share of 67.9% in 2024, driven by its effectiveness in delivering localized shockwaves to modify calcified plaques and its widespread adoption in interventional cardiology procedures
